BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26417026)

  • 21. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
    Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
    J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
    Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
    Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Skip metastasis to mediastinal lymph nodes: clinical significance and prognosis in stage III non-small cell lung cancer].
    Chen QK; Ding JA; Gao W; Zhu YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):472-4. PubMed ID: 16115397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and utility of mediastinoscopy in non-small cell lung cancer in a complex mediastinum.
    Louie BE; Kapur S; Farivar AS; Youssef SJ; Gorden J; Aye RW; Vallières E
    Ann Thorac Surg; 2011 Jul; 92(1):278-82; discussion 282-3. PubMed ID: 21616475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and prognostic analysis of skip N2 metastases in stage IIIA-N2 non-small cell lung cancer].
    Zhang LM; Zhang ZF; Wang CL
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):780-3. PubMed ID: 20646498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platinum Drug Sensitivity Polymorphisms in Stage III Non-small Cell Lung Cancer With Invasion of Mediastinal Lymph Nodes.
    Nastase A; Lupo A; Laszlo V; Damotte D; Dima S; Canny E; Alifano M; Popescu I; Klepetko W; Grigoroiu M
    Cancer Genomics Proteomics; 2020; 17(5):587-595. PubMed ID: 32859637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
    Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
    J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of clinical stage IIIA primary lung cancers in the National Cancer Database.
    Hancock J; Rosen J; Moreno A; Kim AW; Detterbeck FC; Boffa DJ
    Ann Thorac Surg; 2014 Aug; 98(2):424-32; discussion 432. PubMed ID: 24929895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.